{
  "approved_at_utc": null,
  "subreddit": "investing",
  "selftext": "DePuy Synthes of Johnson and Johnson have sponsored a four year trial in a regenerative stem-cell treatment trial taking patients' own tendon stem cells via a quick biopsy (tenocytes), culturing cells and reinjecting into the degenerative tendon.\n\nResults about to be announced by their four year trial partner Orthocell (OCC) on the ASX.  This is an at least $10 billion market that not only can replace unecessary and expensive surgeries in many cases but also meet unmet needs.\n\nThe companies results to date have shown near 90% success rates:\n\nhttps://www.google.com/amp/s/www.proactiveinvestors.com.au/companies/amp/news/923762\n\n\nThe FDA has just granted approval for an autologous stem cell trial.in MS for those concerned there.",
  "author_fullname": "t2_a2mgjdq9",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Johnson and Johnson about to announce 4 year results in collaborative study",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/investing",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": null,
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_p2rdap",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.92,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 271,
  "total_awards_received": 0,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": null,
  "can_mod_post": false,
  "score": 271,
  "approved_by": null,
  "is_created_from_ads_ui": false,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1628733697,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.investing",
  "allow_live_comments": true,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>DePuy Synthes of Johnson and Johnson have sponsored a four year trial in a regenerative stem-cell treatment trial taking patients&#39; own tendon stem cells via a quick biopsy (tenocytes), culturing cells and reinjecting into the degenerative tendon.</p>\n\n<p>Results about to be announced by their four year trial partner Orthocell (OCC) on the ASX.  This is an at least $10 billion market that not only can replace unecessary and expensive surgeries in many cases but also meet unmet needs.</p>\n\n<p>The companies results to date have shown near 90% success rates:</p>\n\n<p><a href=\"https://www.google.com/amp/s/www.proactiveinvestors.com.au/companies/amp/news/923762\">https://www.google.com/amp/s/www.proactiveinvestors.com.au/companies/amp/news/923762</a></p>\n\n<p>The FDA has just granted approval for an autologous stem cell trial.in MS for those concerned there.</p>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qhhq",
  "author_is_blocked": false,
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "",
  "id": "p2rdap",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "Historical_Job_8609",
  "discussion_type": null,
  "num_comments": 21,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/",
  "subreddit_subscribers": 1897145,
  "created_utc": 1628775039,
  "num_crossposts": 3,
  "media": null,
  "is_video": false,
  "original_created_utc": 1628733697,
  "the_new_excerpt": "DePuy Synthes of Johnson and Johnson have sponsored a four year trial in a\nregenerative stem-cell treatment trial taking patients' own tendon stem cells\nvia a quick biopsy (tenocytes), culturing cells and reinjecting into the\ndegenerative tendon.\n\nResults about to be announced by their four year…",
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "ジョンソン・アンド・ジョンソン社のデピュー・シンセシス社がスポンサーとなって、4年間の再生幹細胞治療試験を行っています。\n患者さん自身の腱の幹細胞を採取して（腱細胞）、培養して\nを採取し、細胞を培養して、変性した腱に再注入するという再生治療の試験を行っています。\n変性した腱に再注入するというものです。\n\nその4年間の結果が発表されようとしています...",
      "title": "ジョンソン・アンド・ジョンソン、共同研究の4年間の成果を発表へ"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "强生公司旗下的DePuy Synthes公司赞助了一项为期四年的试验。\n再生干细胞治疗试验。\n通过快速活检(tenocytes)，培养细胞并重新注射到患者的肌腱中。\n退化的肌腱。\n\n其四年的试验结果即将公布。",
      "title": "强生公司即将宣布合作研究的4年结果"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "強生公司旗下的DePuy Synthes公司贊助了一項爲期四年的試驗。\n再生幹細胞治療試驗。\n通過快速活檢(tenocytes)，培養細胞並重新注射到患者的肌腱中。\n退化的肌腱。\n\n其四年的試驗結果即將公佈。",
      "title": "強生公司即將宣佈合作研究的4年結果"
    }
  ],
  "source_updated_at": 1629452482611
}